Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Gene|October 28, 2017
Correlation between telomerase and mTOR pathway in cancer stem cellsFatma Dogan, Cigir Biray Avci
Molecular Neurobiology|July 16, 2026
Therapeutic Potential of Mesenchymal Stem Cells in Multiple Sclerosis: An Updated ReviewIrem Yildirim, Cigir Biray Avci
Journal of Drug Targeting|September 26, 2018
Application of titanium dioxide (TiO2) nanoparticles in cancer therapiesSelin Çeşmeli, Cigir Biray Avci
Journal of Cellular Biochemistry|August 27, 2018
Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignanciesCigir Biray Avci, Fatma Dogan, Neslihan Pinar Ozates Ay, et al.
Molecular Biology Reports|March 1, 2020
Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cellsHasan Onur Caglar, Cigir Biray Avci
Medical Oncology (Northwood, London, England)|July 14, 2022
Molecular perspective on targeted therapy in breast cancer: a review of current statusBusra Demir Cetinkaya, Cigir Biray Avci
Cytokine & Growth Factor Reviews|July 9, 2020
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19Bakiye Goker Bagca, Cigir Biray Avci
Gene|September 6, 2015
Role of mTOR in glioblastomaZekeriya Duzgun, Zuhal Eroglu, Cigir Biray Avci
Medical Oncology (Northwood, London, England)|August 16, 2022
Chk1/2 inhibitor AZD7762 enhances the susceptibility of IDH-mutant brain cancer cells to temozolomideErkin Ozgiray, Fatma Sogutlu, Cigir Biray Avci
Pageof 14